Catalyst Pharmaceuticals Inc (CPRX)
Equity Ratio
88.24%
Quarterly · Period ending:
CPRX Equity Ratio
Latest reported88.24%period ending
Latest reported88.24%period ending
CPRX Quarterly Equity Ratio (63.43% → 88.24%)
Latest values, visible window
High-resolution chart · PNG
CPRX equity ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Equity Ratio |
|---|---|
| 88.244% | |
| 86.2178% | |
| 87.5089% | |
| 88.0763% | |
| 87.3922% | |
| 85.4619% | |
| 85.613% | |
| 86.1678% | |
| 86.815% | |
| 82.5079% | |
| 84.3511% | |
| 84.5455% | |
| 81.9349% | |
| 79.9779% | |
| 81.0656% | |
| 90.1922% | |
| 89.1684% | |
| 86.9813% | |
| 88.9867% | |
| 90.3476% | |
| 90.5865% | |
| 88.1697% | |
| 89.5734% | |
| 84.6206% | |
| 84.5572% | |
| 77.9791% | |
| 80.6517% | |
| 80.8872% | |
| 83.7889% | |
| 84.0097% | |
| 94.6341% | |
| 95.6583% | |
| 96.3581% | |
| 94.8194% | |
| 91.62% | |
| 94.411% | |
| 93.1003% | |
| 94.2505% | |
| 94.6818% | |
| 94.6554% | |
| 94.169% | |
| 92.3043% | |
| 93.9392% | |
| 91.8862% | |
| 87.6036% | |
| 80.2639% | |
| 79.8846% | |
| 89.6767% | |
| 79.3461% | |
| 84.3186% | |
| 77.0834% | |
| 78.4712% | |
| 89.2977% | |
| 87.0922% | |
| 77.6105% | |
| 83.2146% | |
| 54.4543% | |
| 60.1783% | |
| 90.1657% | |
| 88.3044% | |
| 87.7996% | |
| 94.6204% | |
| 93.5337% | |
| 91.5655% | |
| 94.5796% | |
| 95.6251% | |
| 93.7909% | |
| 92.1719% | |
| 82.9541% | |
| 87.7607% | |
| 91.7488% | |
| 94.1716% | |
| 96.8421% | |
| 97.8587% | |
| 97.6977% | |
| 97.7065% | |
| 97.2942% | |
| 96.2519% | |
| 80.4522% | |
| -18.9634% | |
| 56.5535% | |
| 63.4257% |